🇺🇸 FDA
Patent

US 8318483

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

granted A61KA61K35/12A61K35/50

Quick answer

US patent 8318483 (Postpartum cells derived from umbilical cord tissue, and methods of making and using the same) held by Advanced Technologies and Regenerative Medicine, LLC expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Advanced Technologies and Regenerative Medicine, LLC
Grant date
Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/12, A61K35/50, A61K35/51, A61K38/18